Sterling Investment Advisors, Ltd. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sterling Investment Advisors, Ltd. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$14,000
-48.1%
3,1500.0%0.01%
-37.5%
Q1 2022$27,000
-40.0%
3,1500.0%0.01%
-38.5%
Q4 2021$45,000
-34.8%
3,1500.0%0.01%
-38.1%
Q3 2021$69,000
+64.3%
3,1500.0%0.02%
+75.0%
Q2 2021$42,000
+31.2%
3,1500.0%0.01%
+20.0%
Q1 2021$32,000
+146.2%
3,1500.0%0.01%
+150.0%
Q4 2020$13,000
+62.5%
3,1500.0%0.00%
+33.3%
Q3 2020$8,000
-27.3%
3,1500.0%0.00%
-40.0%
Q2 2020$11,000
+22.2%
3,1500.0%0.01%0.0%
Q1 2020$9,000
-43.8%
3,1500.0%0.01%
-28.6%
Q4 2019$16,000
+60.0%
3,1500.0%0.01%
+40.0%
Q3 2019$10,000
-9.1%
3,1500.0%0.01%
-16.7%
Q2 2019$11,0000.0%3,1500.0%0.01%0.0%
Q1 2019$11,000
+22.2%
3,1500.0%0.01%
+20.0%
Q4 2018$9,000
-40.0%
3,1500.0%0.01%
-37.5%
Q3 2018$15,000
-34.8%
3,1500.0%0.01%
-42.9%
Q2 2018$23,000
+9.5%
3,1500.0%0.01%
+7.7%
Q1 2018$21,000
-25.0%
3,1500.0%0.01%
-23.5%
Q4 2017$28,000
-9.7%
3,1500.0%0.02%
-19.0%
Q3 2017$31,000
+29.2%
3,1500.0%0.02%
+31.2%
Q2 2017$24,000
+26.3%
3,1500.0%0.02%
+14.3%
Q1 2017$19,0000.0%3,1500.0%0.01%
-6.7%
Q4 2016$19,0003,1500.02%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders